$kzia and $vrpx shares skyrocketing 07/10/24

&kzia shares rose up to 350%. The catalyst is the positive results from a study of its anticancer medication paxalisix indicated to treat gliobkastoma. This is the second rising star stock for the day. The other stock $vrpx shares also rose to up to 150%. The rise was triggered by study news indicating the efficacy of a painkiller.

Today overall market is bullish and three major indexes and all market sectors are all green. A stock of a drug company performed extraordinarily good yesterday which may have boosted the traders' confidence for today's market.